Track the 대원제약 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 대원제약 has published 1 insider filings. Market capitalisation: €158.4bn. The latest transaction was reported on 13 March 2026 (Purchase). Among the most active insiders: 임한일. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Daewon Pharmaceutical es una empresa surcoreana especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XKRX.